Search company, investor...

Predict your next investment

Venture Capital
rosecliff.com

Investments

78

Portfolio Exits

6

Funds

7

Service Providers

1

About Rosecliff Ventures

Rosecliff Ventures is a venture capital firm investing in startup enterprises and innovative ideas that have substantial growth potential. The firm's goal is to invest in dynamic founders and help them realize their dreams. Rosecliff will seek to invest predominately in early stage venture opportunities.

Headquarters Location

245 5th Avenue 14th Floor

New York, New York, 10016,

United States

212-492-3000

Want to inform investors similar to Rosecliff Ventures about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Latest Rosecliff Ventures News

Lifeforce: $12 Million Raised For Health Optimization Platform

May 30, 2023

Lifeforce – which is the first comprehensive and clinically integrated health optimization platform – announced the closing of its $12 million Series A funding round co-led by M13 and Peterson Ventures. The oversubscribed funding round also includes participation by Ridgeline Ventures, Rosecliff Ventures, and Seaside Ventures. In a fragmented healthcare market, Lifeforce is operating as the trusted partner for people seeking to take proactive control of their health by bringing together the biomarker data, clinical expertise, and validated interventions needed to optimize health and longevity. This company was incubated by M13’s in-house venture studio Launchpad – which has built multiple businesses in the health and wellness space. And the company is additionally backed by some of the most influential figures in health and human performance including renowned author and Lifeforce Co-Founder Tony Robbins; technologist, physician, engineer, and Lifeforce Co-Founder Dr. Peter Diamandis; and professional tennis legend Serena Williams. Using a convenient telehealth-driven model, Lifeforce lowers cost, reduces friction, and makes personalized health optimization more accessible. And members receive regular in-home diagnostic blood tests from registered phlebotomists who are covering the 40-plus biomarkers most important to physical, cognitive, sexual, and psychological performance. The results are then interpreted by a team of trained medical doctors to create a personalized program of scientifically validated lifestyle adjustments, nutraceuticals, and hormone and peptide therapies customized to each member’s biology and goals. And unlike most other longevity platforms, members also have direct ongoing access to specialized clinicians and health coaches and are re-tested every three months to track progress and refine programs accordingly. Lifeforce’s model was developed with the guidance of an expert Advisory Board including Dr. Mark Hyman, Head of Strategy and Innovation of the Cleveland Clinic Center for Functional Medicine; Dr. Fatima Cody Stanford, Weight Management Expert and Associate professor at Harvard Medical School; Dr. Rudy Tanzi, Harvard Medical School Vice-Chair of Neurology and Massachusetts General Hospital Director and Dr. Kathryn Rexrode, Chief of the Division of Women’s Health in the Department of Medicine at Brigham and Women’s Hospital (BWH) and a Professor of Medicine at Harvard Medical School. At a fraction of the cost of other offerings, a Lifeforce membership has a starting price of $349 for an initial baseline assessment and $129 per month for membership thereafter. What the funding will be used for: This latest round of financing enables Lifeforce to accelerate growth, expand its offering, and cement its position as the world’s leading health optimization platform. And the company is also working on data tools that will allow it to further improve the efficacy of its personalized programs while lowering costs. KEY QUOTES: “No one should have to settle for feeling average as they age. People want a convenient solution for functioning at their best, and the peace of mind that they are on the right track to live a long and healthy life. Eighty-five percent of Lifeforce members report improved quality of life within the first three months of being on a Lifeforce program. We analyze key biomarkers to find out where people are sub-optimal and close those gaps so they can feel stronger, think clearer, and live longer.” — Dugal Bain-Kim, co-founder and CEO of Lifeforce “I’ve spent 35 years helping people unlock their potential. Over that time I’ve learned that if you’re not in the driver’s seat of your health, you’re not going to be your most powerful self. So much more is possible in life when you decide to be proactive and assert yourself as the CEO of your own health. We launched Lifeforce to make it easier for people to do that.” — Tony Robbins, Co-Founder, Lifeforce “Lifeforce is poised to have a transformative impact, not just redefining the health optimization category but the very way we think about what’s possible as we age. Demand for personalized proactive healthcare is growing exponentially and the team’s collective expertise in health, technology, and business uniquely positions Lifeforce to meet this demand.” — Courtney Reum, Lifeforce Board Chairman and Co-founder at M13 “Lifeforce is a comprehensive, convenient platform that takes the guesswork out of balancing hormones, nutrients, metabolism, and organ health so we not only live longer but live better.” — Mark Hyman, MD, Lifeforce Advisor Trending on Pulse 2.0

Rosecliff Ventures Investments

78 Investments

Rosecliff Ventures has made 78 investments. Their latest investment was in Lifeforce as part of their Series A on May 5, 2023.

CBI Logo

Rosecliff Ventures Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

5/23/2023

Series A

Lifeforce

$12M

Yes

3

1/3/2023

Series E

Anokiwave

$4.79M

Yes

1

7/28/2022

Seed VC

Revolv3

$4.5M

Yes

Rosecliff Ventures, and Undisclosed Angel Investors

3

2/7/2022

Series A

Subscribe to see more

$99M

Subscribe to see more

10

12/6/2021

Seed VC - II

Subscribe to see more

$99M

Subscribe to see more

10

Date

5/23/2023

1/3/2023

7/28/2022

2/7/2022

12/6/2021

Round

Series A

Series E

Seed VC

Series A

Seed VC - II

Company

Lifeforce

Anokiwave

Revolv3

Subscribe to see more

Subscribe to see more

Amount

$12M

$4.79M

$4.5M

$99M

$99M

New?

Yes

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Rosecliff Ventures, and Undisclosed Angel Investors

Sources

3

1

3

10

10

Rosecliff Ventures Portfolio Exits

6 Portfolio Exits

Rosecliff Ventures has 6 portfolio exits. Their latest portfolio exit was Gatsby on August 17, 2022.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

8/17/2022

Acquired

$99M

11

11/3/2021

IPO

Subscribe to see more

$99M

Subscribe to see more

10

3/26/2021

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

7/13/2020

Asset Sale

Subscribe to see more

$99M

Subscribe to see more

10

2/11/2019

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

8/17/2022

11/3/2021

3/26/2021

7/13/2020

2/11/2019

Exit

Acquired

IPO

Acquired

Asset Sale

Acquired

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

11

10

10

10

10

Rosecliff Ventures Fund History

7 Fund Histories

Rosecliff Ventures has 7 funds, including Rosecliff Credit Opportunity Fund I.

Closing Date

Fund

Fund Type

Status

Amount

Sources

6/29/2020

Rosecliff Credit Opportunity Fund I

$150M

1

3/31/2019

Rosecliff Venture Partners IV

Subscribe to see more

Subscribe to see more

10

12/31/2018

Rosecliff Venture Partners III

Subscribe to see more

Subscribe to see more

10

6/20/2018

Rosecliff Venture Partners II

Subscribe to see more

Subscribe to see more

$99M

10

11/14/2016

Rosecliff Venture Partners

Subscribe to see more

Subscribe to see more

$99M

10

Closing Date

6/29/2020

3/31/2019

12/31/2018

6/20/2018

11/14/2016

Fund

Rosecliff Credit Opportunity Fund I

Rosecliff Venture Partners IV

Rosecliff Venture Partners III

Rosecliff Venture Partners II

Rosecliff Venture Partners

Fund Type

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$150M

$99M

$99M

Sources

1

10

10

10

10

Rosecliff Ventures Service Providers

1 Service Provider

Rosecliff Ventures has 1 service provider relationship

Service Provider

Associated Rounds

Provider Type

Service Type

Counsel

General Counsel

Service Provider

Associated Rounds

Provider Type

Counsel

Service Type

General Counsel

Partnership data by VentureSource

Rosecliff Ventures Team

1 Team Member

Rosecliff Ventures has 1 team member, including current Founder, Managing Partner, Michael P. Murphy.

Name

Work History

Title

Status

Michael P. Murphy

Founder, Managing Partner

Current

Name

Michael P. Murphy

Work History

Title

Founder, Managing Partner

Status

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Join a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.